AQST
Aquestive Therapeutics Inc.
Company Overview
| Mkt Cap | $565.43M | Price | $6.82 |
| Volume | 1.75M | Change | +2.40% |
| P/E Ratio | -12.8 | Open | $6.68 |
| Revenue | $57.6M | Prev Close | $6.66 |
| Net Income | $-44.1M | 52W Range | $2.12 - $7.55 |
| Div Yield | N/A | Target | $9.08 |
| Overall | 55 | Value | 40 |
| Quality | 60 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyAquestive Therapeutics Inc. (AQST) is a leading Healthcare company in the Biotechnology industry, currently trading at $6.82 with a market capitalization of $565.43 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AQST with a volume of 1.75 million shares. The stock opened up 0.30% from yesterday's close of $6.66. Current analyst estimates project earnings of $-0.63 per share for this year, with next year targeting $-0.56.
AQST demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for AQST include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 33.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 11:52 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AQST | $6.82 | +2.4% | 1.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aquestive Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW